Anderson Hoagland & Co’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.5M Buy
22,936
+945
+4% +$966K 2.16% 13
2026
Q1
$20.2M Buy
21,991
+1,409
+7% +$1.43M 1.74% 16
2025
Q4
$22.1M Sell
20,582
-2,020
-9% -$1.93M 1.9% 13
2025
Q3
$17.2M Sell
22,602
-89
-0.4% -$66.2K 1.55% 16
2025
Q2
$17.7M Buy
22,691
+44
+0.2% +$34.2K 1.69% 14
2025
Q1
$16.4M Hold
22,647
1.95% 14
2024
Q4
$16.4M Sell
22,647
-132
-0.6% -$109K 1.69% 15
2024
Q3
$20.2M Sell
22,779
-27
-0.1% -$24.3K 2.06% 14
2024
Q2
$21.3M Sell
22,806
-17
-0.1% -$13.6K 2.23% 10
2024
Q1
$17.4M Buy
22,823
+260
+1% +$185K 1.95% 14
2023
Q4
$14.3M Hold
22,563
1.76% 17
2023
Q3
$12.1M Buy
22,563
+668
+3% +$344K 1.62% 16
2023
Q2
$10.3M Hold
21,895
1.32% 20
2023
Q1
$7.52M Buy
21,895
+407
+2% +$137K 1.08% 25
2022
Q4
$7.54M Buy
21,488
+778
+4% +$276K 1.1% 27
2022
Q3
$6.7M Buy
20,710
+1,919
+10% +$608K 1.07% 29
2022
Q2
$6.16M Buy
18,791
+6,073
+48% +$1.82M 0.93% 31
2022
Q1
$3.64M Sell
12,718
-114
-0.9% -$29.3K 0.47% 54
2021
Q4
$3.08M Buy
12,832
+163
+1% +$41.3K 0.4% 62
2021
Q3
$2.93M Sell
12,669
-102
-0.8% -$25.2K 0.37% 68
2021
Q2
$2.93M Buy
12,771
+156
+1% +$31.3K 0.37% 69
2021
Q1
$2.36M Hold
12,615
0.33% 73
2020
Q4
$2.13M Buy
12,615
+5,567
+79% +$831K 0.34% 72
2020
Q3
$1.06M Buy
+7,048
New +$1.09M 0.51% 54

Other funds holding LLY

Anderson Hoagland & Co's LLY Position: Q2 2026 in Review

Anderson Hoagland & Co increased its Eli Lilly (LLY) stake by 4.3% in Q2 2026, buying an estimated $966K and bringing the position to 22,936 shares worth $27.5M. The position accounts for 2.16% of the portfolio, ranked #13.

Anderson Hoagland & Co first reported a position in LLY in Q3 2020 and has held it in 24 quarters since. 1,343 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Anderson Hoagland & Co held 22,936 shares of Eli Lilly worth $27.5M as of Q2 2026.
  • Anderson Hoagland & Co bought 945 Eli Lilly shares in Q2 2026, an estimated $966K.
  • Eli Lilly made up 2.16% of Anderson Hoagland & Co's portfolio in Q2 2026, its #13 holding.
  • Anderson Hoagland & Co first reported a position in Eli Lilly in Q3 2020 and has held it in 24 quarters since.
  • 1,343 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Anderson Hoagland & Co's 13F filing for Q2 2026, filed 6 Jul 2026.